Parallel Advisors, LLC Mesoblast LTD Transaction History

Parallel Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 20, 2024	BUY	$2.94 - $4.18 $558 - $794	190 New	190 $0
Q1 2023 Apr 25, 2023	BUY	$2.94 - $4.18 $558 - $794	190 New	190 $0
Q2 2022 Aug 01, 2022	SELL	$2.22 - $4.54 $370 - $758	-167 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$3.58 - $4.98 $2,076 - $2,888	-580 Reduced 77.64%	167 $1,000
Q4 2021 Jan 20, 2022	BUY	$4.17 - $7.09 $179 - $304	43 Added 6.11%	747 $4,000
Q3 2020 Oct 27, 2020	SELL	$11.33 - $19.81 $985 - $1,723	-87 Reduced 11.0%	704 $13,000
Q2 2020 Jul 16, 2020	BUY	$4.2 - $15.45 $3,322 - $12,220	791 New	791 $9,000
Q1 2020 Apr 27, 2020	SELL	$3.38 - $10.63 $1,821 - $5,729	-539 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$4.67 - $5.88 $2,517 - $3,169	539 New	539 $3,000
Q4 2018 Feb 05, 2019	SELL	$3.51 - $8.6 $2,937 - $7,198	-837 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$5.75 - $8.16 $3,277 - $4,651	570 Added 213.48%	837 $7,000
Q1 2018 May 08, 2018	BUY	$4.91 - $7.72 $1,310 - $2,061	267 New	267 $2,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.57B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.